| Year |
Citation |
Score |
| 2018 |
Wilhite TJ, Routman D, Arnett AL, Glasgow AE, Habermann EB, Pisansky TM, Boorjian SA, Jethwa KR, Mynderse LA, Roberts KW, Frank I, Choo R, Davis BJ, Stish BJ. Increased utilization of external beam radiotherapy relative to cystectomy for localized, muscle-invasive bladder cancer: a SEER analysis. Bladder (San Francisco, Calif.). 5: e34. PMID 32775476 DOI: 10.14440/bladder.2018.639 |
0.306 |
|
| 2014 |
Arnett AL, Konieczny P, Ramos JN, Hall J, Odom G, Yablonka-Reuveni Z, Chamberlain JR, Chamberlain JS. Adeno-associated viral (AAV) vectors do not efficiently target muscle satellite cells. Molecular Therapy. Methods & Clinical Development. 1. PMID 25580445 DOI: 10.1038/Mtm.2014.38 |
0.58 |
|
| 2014 |
Swiderski K, Shaffer SA, Gallis B, Odom GL, Arnett AL, Scott Edgar J, Baum DM, Chee A, Naim T, Gregorevic P, Murphy KT, Moody J, Goodlett DR, Lynch GS, Chamberlain JS. Phosphorylation within the cysteine-rich region of dystrophin enhances its association with β-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wasting. Human Molecular Genetics. 23: 6697-711. PMID 25082828 DOI: 10.1093/Hmg/Ddu388 |
0.52 |
|
| 2013 |
Arnett AL, Beutler LR, Quintana A, Allen J, Finn E, Palmiter RD, Chamberlain JS. Heparin-binding correlates with increased efficiency of AAV1- and AAV6-mediated transduction of striated muscle, but negatively impacts CNS transduction. Gene Therapy. 20: 497-503. PMID 22855092 DOI: 10.1038/Gt.2012.60 |
0.516 |
|
| 2011 |
Arnett AL, Garikipati D, Wang Z, Tapscott S, Chamberlain JS. Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector. Frontiers in Microbiology. 2: 220. PMID 22065964 DOI: 10.3389/Fmicb.2011.00220 |
0.366 |
|
| 2011 |
Judge LM, Arnett AL, Banks GB, Chamberlain JS. Expression of the dystrophin isoform Dp116 preserves functional muscle mass and extends lifespan without preventing dystrophy in severely dystrophic mice. Human Molecular Genetics. 20: 4978-90. PMID 21949353 DOI: 10.1093/Hmg/Ddr433 |
0.546 |
|
| 2010 |
Wang Z, Storb R, Lee D, Kushmerick MJ, Chu B, Berger C, Arnett A, Allen J, Chamberlain JS, Riddell SR, Tapscott SJ. Immune responses to AAV in canine muscle monitored by cellular assays and noninvasive imaging. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 617-24. PMID 20040912 DOI: 10.1038/Mt.2009.294 |
0.483 |
|
| 2009 |
Arnett AL, Chamberlain JR, Chamberlain JS. Therapy for neuromuscular disorders. Current Opinion in Genetics & Development. 19: 290-7. PMID 19411172 DOI: 10.1016/J.Gde.2009.03.005 |
0.485 |
|
| Show low-probability matches. |